Alkylating agent causing DNA crosslinking (None established)

Alkylating agents causing DNA crosslinking are a class of chemotherapeutic drugs that exert their cytotoxic effects by transferring alkyl groups onto nucleophilic sites within cellular macromolecules—most importantly the nitrogenous bases in genomic DNA. Bifunctional variants can form covalent bridges either within one strand or between both strands ("crosslinks"), which block essential processes such as replication and transcription. This leads ultimately to cell cycle arrest and apoptosis if repair mechanisms fail. These compounds have been foundational in cancer therapy since their introduction following observations from chemical warfare research during World War II. While highly effective against rapidly dividing cells such as those found in many cancers, they lack specificity for malignant cells over normal proliferative tissues—a limitation reflected in their significant side effect profiles including bone marrow suppression, gastrointestinal injury, infertility risks, and potential induction of secondary cancers through mutagenesis[1][2][3].

Other names

DNA alkylatorDNA crosslinkerAlkylating antineoplastic agentBifunctional alkylating agent

Covalent binding to nucleophilic sites on DNA bases—primarily the N7 position on guanine—resulting in the formation of intra-strand and inter-strand crosslinks[1][2][3]. Crosslinks prevent proper separation and replication/transcription of the double helix, leading to replication arrest and cell death if unrepaired. Some also form covalent bonds between DNA and proteins ("DNA-protein crosslinks")[1].